Concord manufactures fermentation and semi-synthetic based products in the therapeutic segments such as Immunosuppressants, Anti-bacterial, Oncology, Anti-fungals & others. This wide range of products has attracted customers across the globe. Concord also has a robust pipeline of products under development.

S. No Product Usage/ Therapeutic Segment
1 Tacrolimus(*) Immunosuppressant
2 Mycophenolate Mofetil
3 Mycophenolate Sodium
4 Cyclosporine
5 Sirolimus
6 Pimecrolimus
7 Mupirocin Anti-bacterials
8 Mupirocin Calcium
9 Vancomycin Hydrochloride
10 Teicoplanin
11 Anidulafungin Anti-fungals
12 Micafungin Sodium 
13 Caspofungi
14 Temsirolimus Oncology Drugs 
15 Everolimus(**)
16 Romidepsin
17 Mitomycin
18 Dactinomycin
19 Midostaurin
20 Lovastatin Others
21 Pravastatin Sodium
S. No Molecule Therapy Area
1 Polymyxin B Anti-infectives
2 Fidaxomicin
3 Daptomycin
4 Nystatin
5 Epirubicin Oncology
6 Doxorubicin
7 Idarubicin
8 Pirarubicin

For more information on API's, please send your enquiry to:

Note : Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and liability for patent infringement is exclusively understood at buyer's risk.